In Brief This Week: Thermo Fisher; PerkinElmer; Life Technologies, Unisone; DiaTech Oncology; MRC-NIHR Phenome Centre; BioFire Diagnostics; More | GenomeWeb

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific priced the $2.2 billion public offering of its stock at $85.50 per share. The company will offer about 25.7 million shares of its stock in connection to the offering, and proceeds will be used to fund, in part, its $13.6 billion acquisition of Life Technologies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

HHS Secretary Tom Price says the NIH budget contains unneeded expenses that can be trimmed, Stat News reports.

The chair of the House science committee says the journal Science is not objective, the Huffington Post reports.

In Nature this week: glioma GWAS uncovers new risk loci, and more.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.